Min Wu
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
Papers in
-
- Vibrio bacteria research studies 18
- Immunology 69
- Immune Response and Inflammation 19
- Co-authors
- Julia Xiaojun ZhaoXia ZhaoQinqin PuWeiqi HongYang YangHongyi LiMengyuan HuangXu Wu
- Journals
- Signal Transduction and Targeted Therapy (16 papers)The Journal of Immunology (13 papers)PLoS ONE (10 papers)Precision Clinical Medicine (6 papers)Scientific Reports (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Min Wu
367 papers receiving 14.0k citations
Hit Papers
Peers
Comparison fields: 5 of 194
- Molecular Medicine 777
- Endocrinology 599
- Molecular Biology 7.4k
- Microbiology 660
- Immunology 1.8k
Countries citing papers authored by Min Wu
This map shows the geographic impact of Min Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Wu more than expected).
Fields of papers citing papers by Min Wu
This network shows the impact of papers produced by Min Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Wu. The network helps show where Min Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 14 | |
| 11 | 2021 | 46 | |
| 12 | 2020 | 104 | |
| 13 | 2020 | 70 | |
| 14 | 2020 | 42 | |
| 15 | 2019 | 43 | |
| 16 | 2018 | 282 | |
| 17 | 2017 | 11 | |
| 18 | 2017 | 16 | |
| 19 | 2016 | 93 | |
| 20 | 2013 | 85 |
About Min Wu
Min Wu is a scholar working on Endocrinology, Immunology, Molecular Medicine, Microbiology and Molecular Biology, having authored 378 papers that have together received 14.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (21 papers), Autophagy in Disease and Therapy (21 papers), Immune Response and Inflammation (19 papers), Bacterial biofilms and quorum sensing (18 papers), Vibrio bacteria research studies (18 papers), Bacterial Genetics and Biotechnology (18 papers), Plant Molecular Biology Research (15 papers) and Neonatal Respiratory Health Research (14 papers). The work is most often cited by research in Molecular Medicine (777 citations), Endocrinology (599 citations), Molecular Biology (7.4k citations), Microbiology (660 citations) and Immunology (1.8k citations). Min Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Julia Xiaojun Zhao, Xia Zhao, Qinqin Pu, Weiqi Hong, Yang Yang, Hongyi Li, Mengyuan Huang, Xu Wu, Shugang Qin and Xin Deng. Their work appears in journals such as Signal Transduction and Targeted Therapy, The Journal of Immunology, PLoS ONE, Precision Clinical Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.